Results

The CANVAS Network is a national platform that monitors vaccine safety after they are approved for use

The network studies complement Canada's passive vaccine safety surveillance system by providing rapid information in early stages of each vaccine campaign​

canvas-network-homepage3-small-1.png

Study Results

COVID-19

Vaccine safety results showing health problems which occurred after the primary series of pandemic COVID-19 vaccine

INFLUENZA

Vaccine safety after pandemic vaccine campaigns such as H1N1 Influenza vaccine (2009) and seasonal Influenza vaccines (2009-2019 and 2022-present)

MENB

MenB safety surveillance studies conducted following immunization with Meningococcal Serogroup B vaccine

Mpox

Vaccine safety results showing health problems after an Imvamune (MPox) vaccine

COVID-19/INFLUENZA

Vaccine safety results following COVID-19 and/or Influenza vaccine. The vaccine co-administration is analyzed in this study

RSV

Will examine safety of RSV vaccines and RSV monoclonal antibodies

Scroll to Top